|
Q3 FY2017
As of Jun 30, 2017
|
Q2 FY2017
As of Mar 31, 2017
|
Q1 FY2017
As of Dec 31, 2016
|
Q4 FY2016
As of Sep 30, 2016
|
Q3 FY2016
As of Jun 30, 2016
|
Q2 FY2016
As of Mar 31, 2016
|
Q1 FY2016
As of Dec 31, 2015
|
Q4 FY2015
As of Sep 30, 2015
|
Q3 FY2015
As of Jun 30, 2015
|
Q2 FY2015
As of Mar 31, 2015
|
Q1 FY2015
As of Dec 31, 2014
|
Q4 FY2014
As of Sep 30, 2014
|
Q3 FY2014
As of Jun 30, 2014
|
Q2 FY2014
As of Mar 31, 2014
|
Q1 FY2014
As of Dec 31, 2013
|
Q4 FY2013
As of Sep 30, 2013
|
Q3 FY2013
As of Jun 30, 2013
|
Q2 FY2013
As of Mar 31, 2013
|
Q1 FY2013
As of Dec 31, 2012
|
Q4 FY2012
As of Sep 30, 2012
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Income tax receivable | ||||||||||||||||||||
| Inventories of materials and supplies, net | ||||||||||||||||||||
| Prepaid expenses, deferred costs and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Other receivables | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Deferred costs and other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||
| Interest payable | ||||||||||||||||||||
| Income tax payable | ||||||||||||||||||||
| Deferred credits and other liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Deferred credits | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Total long-term liabilities | ||||||||||||||||||||
| Preferred stock, no par value, 1,000 shares authorized, none outstanding | ||||||||||||||||||||
| Common stock, $1.00 par value, 180,000 shares authorized with 80,544 issued (Note 10) and outstanding as of June 30, 2017 and 180,000 shares authorized and 64,799 shares issued and outstanding as of September 30, 2016 | ||||||||||||||||||||
| Paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||||||
Loading...
